Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spire (US) launches Spi-Polymer surface treatment:

This article was originally published in Clinica

Executive Summary

Spire (US) has developed the Spi-Polymer process which reduces biofouling on the surface of polymeric components of IVD assay devices. The surface treatment is applied to devices using ion implantation technology, providing a more hydrophilic surface which reduces blood cell, air bubble and plasma protein adherence. The reduction of biofouling improves accuracy for diagnostic assay systems by enhancing flow performance and reducing maintenance, says Spire.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT093314

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel